Video

Dr. Miller: “No limits” to what HoLEP can offer appropriate patients with BPH

Author(s):

Urology Times staff

“We're doing probably one of the highest volume of HoLEP cases…in the United States,” says Nicole L. Miller, MD, FACS.

In this video, Nicole L. Miller, MD, FACS, discusses what sets her HoLEP practice for treating patients with benign prostatic hyperplasia from other centers. Miller is a professor of urology and fellowship director, Endourology and Laparoscopic Surgery, at Vanderbilt University Medical Center in Nashville, Tennessee.

Related Videos
Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
Ruben Olivares, MD, answers a question during a Zoom video interview
Doctor consulting patient | Image Credit: © Liudmila Dutko - stock.adobe.com
Shot of a doctor showing a patient some information on a digital tablet | Image Credit | © bongkarn - stock.adobe.com
Related Content
Intraprostatic drug elution therapy shows promise for BPH-related LUTS
May 29th 2025

Intraprostatic drug elution therapy shows promise for BPH-related LUTS

Hannah Clarke
Further follow-up and additional treatments in the study are ongoing.
Speaking of Urology: Melissa Kaufman, MD, on AUA’s new guideline on genitourinary syndrome of menopause
April 28th 2025

Speaking of Urology: Melissa Kaufman, MD, on AUA’s new guideline on genitourinary syndrome of menopause

Melissa Kaufman, MD, PhD, FACS
In this episode, guideline chair Melissa Kaufman, MD, PhD, FACS, highlights key points from the new AUA GSM guideline and illustrates its impact for clinical management of this condition.
Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI
May 16th 2025

Addressing an unmet need: CELLEBRATE trial explores cell-based therapy for recurrent SUI

Melissa Kaufman, MD, PhD, FACS Hannah Clarke
The CELLEBRATE trial is aiming to provide additional evidence to support the safety and efficacy of iltamiocel.
male patient sitting in clinic room while doctor talks with him
May 23rd 2023

Dr. Gange discusses data on the UroLift System for BPH

Urology Times staff
The data were presented at the recent American Urological Association Annual Meeting.
Artificial urinary sphincter for SUI shows safety, efficacy in prospective study
May 9th 2025

Artificial urinary sphincter for SUI shows safety, efficacy in prospective study

Melissa Kaufman, MD, PhD, FACS Hannah Clarke
"This trial will be the benchmark for research reporting in the future," says Melissa R. Kaufman, MD, PhD, FACS.
Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
May 1st 2025

Safety, efficacy of vibegron sustained in men with OAB treated for BPH

Benjamin P. Saylor
The investigators reported an overall incidence of AEs of 29.6%.
© 2025 MJH Life Sciences

All rights reserved.